Trademark: 87833163
Status Date
Tuesday, October 29, 2019
Registration Number
5898002
Registration Date
Tuesday, October 29, 2019
Filing Date
Wednesday, March 14, 2018
Published for Opposition
Tuesday, July 31, 2018
5 Therapeutic pharmaceuticals for the treatment of remyelination, diseases of Multiple Sclerosis, and the treatment of cancer
Oct 29, 2019
Registered-Principal Register
Sep 27, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 26, 2019
Allowed Principal Register - Sou Accepted
Sep 23, 2019
Notification Of Non-Final Action E-Mailed
Sep 23, 2019
Non-Final Action E-Mailed
Sep 23, 2019
Su - Non-Final Action - Written
Sep 17, 2019
Statement Of Use Processing Complete
Aug 20, 2019
Use Amendment Filed
Sep 17, 2019
Case Assigned To Intent To Use Paralegal
Aug 20, 2019
Teas Statement Of Use Received
Mar 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2019
Extension 1 Granted
Mar 15, 2019
Extension 1 Filed
Mar 15, 2019
Teas Extension Received
Sep 25, 2018
Noa E-Mailed - Sou Required From Applicant
Jul 31, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 31, 2018
Published For Opposition
Jul 11, 2018
Notification Of Notice Of Publication E-Mailed
Jun 27, 2018
Approved For Pub - Principal Register
Jun 25, 2018
Assigned To Examiner
Mar 20, 2018
New Application Office Supplied Data Entered In Tram
Mar 17, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
